Home › Therapeutic areas › Oncology › Neuroendocrine Tumors
Neuroendocrine Tumors (3 companies)
Companies with an active program in Neuroendocrine Tumors.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals | MetabolicOncology Rare | 2 | Approved | — | 6 |
| EXEL | Exelixis | CardiovascularOncology | 3 | Approved | $17.0B | 23 |
| CATX | Perspective Therapeutics | Oncology | 1 | Phase 1 | $95.9M | 4 |
No companies match.